You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

List of Excipients in API emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 ALUMINUM OXIDE 2033-01-14
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 CELLULOSE, MICROCRYSTALLINE 2033-01-14
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 CROSCARMELLOSE SODIUM 2033-01-14
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 FD&C BLUE NO. 2 2033-01-14
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 FD&C YELLOW NO. 6 2033-01-14
Physicians Total Care Inc COMPLERA emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360 FERRIC OXIDE RED 2033-01-14
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate

Excipient focus: ALUMINUM OXIDE

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing ALUMINUM OXIDE

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: CELLULOSE, MICROCRYSTALLINE

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: CROSCARMELLOSE SODIUM

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: FD&C BLUE NO. 2

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 2

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: FD&C YELLOW NO. 6

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FD&C YELLOW NO. 6

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: FERRIC OXIDE RED

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE RED

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: MAGNESIUM STEARATE

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 20

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POLYSORBATE 20

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: POVIDONE

Excipient focus: POVIDONES

Excipient focus: STARCH, CORN

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing STARCH, CORN

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: TITANIUM DIOXIDE

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: TRIACETIN

emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing TRIACETIN

Glossary
Company Ingredient NDC
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group